Overall rank by patents
#40,796
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 15 technology areas, active 2019–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D01F (CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS).
The verdict
Hyosung holds 6 US patents across 15 technology areas, rank #40,796 of 50,000 tracked assignees.
Hyosung TNC Corporation has been granted 6 US utility patents between 2019 and 2024, placing Hyosung TNC Corporation at rank #40,796 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.5 claims per patent with primary concentration in D01F (CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS). As a Foreign Corporation, Hyosung TNC Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Hyosung sits between Hydril USA Manufacturing Llc (6 patents, rank #40,792) and Hyperspectral Corp. (6 patents, rank #40,800) - the closest US assignees by grant volume. The composite Innovation Score of 27.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 2 in the 2015–2019 window, a +100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Hyosung TNC Corporation's 5.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hyosung TNC Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hydril USA Manufacturing LLC
6 patents
Hydroacoustics Inc.
6 patents
Hyfra Industriekuhlanlagen GmbH
6 patents
Hyosung Chemical Corporation
6 patents
HyperAccel Co., Ltd.
6 patents
HyperBranch Medical Technology, Inc.
6 patents
Hyperframe, Inc.
6 patents
Hyperspectral Corp.
6 patents
Hyosung TNC Corporation
6 patents
What this shows Hyosung holds 6 patents at rank #40,796, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,796 in granted patent volume.
Other assignees with the most granted patents in Hyosung's primary technology class.
Hyosung's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 78% higher than 22% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 33.3% |
| 2020 | 2 | 33.3% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Top 15 of 15 technology areas
Overall rank by patents
#40,796
Across all tracked assignees
27.1 out of 100
How to use this portfolio
Hyosung's 6 grants land it in the top 78% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.